XERIS BIOPHARMA HOLDINGS, INC. Stock Issued
XERIS BIOPHARMA HOLDINGS, INC. (XERS) reported Stock Issued of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-11.
Discontinued › Cash Flow
us-gaap:StockIssued1 · last filed 2022-03-11
- XERIS BIOPHARMA HOLDINGS, INC. stock issued for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- XERIS BIOPHARMA HOLDINGS, INC. stock issued for fiscal 2020 was $37.81M.
| Period end | Stock Issued 12 month |
|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-11 |
| 2020-12-31 | $37.81M 10-K · filed 2022-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |